Engineered T cells secreting αB7-H3-αCD3 bispecific engagers for enhanced anti-tumor activity against B7-H3 positive multiple myeloma: a novel therapeutic approach.
Saved in:
| Title: | Engineered T cells secreting αB7-H3-αCD3 bispecific engagers for enhanced anti-tumor activity against B7-H3 positive multiple myeloma: a novel therapeutic approach. |
|---|---|
| Authors: | Rujirachaivej, Punchita1 (AUTHOR), Siriboonpiputtana, Teerapong2 (AUTHOR), Choomee, Kornkan3,4 (AUTHOR), Supimon, Kamonlapat3,4 (AUTHOR), Sangsuwannukul, Thanich5 (AUTHOR), Songprakhon, Pucharee3,4 (AUTHOR), Natungnuy, Krissada3,4 (AUTHOR), Luangwattananun, Piriya3,4 (AUTHOR), Yuti, Pornpimon3,4 (AUTHOR), Junking, Mutita3,4 (AUTHOR) mjunking@gmail.com, Yenchitsomanus, Pa-thai3,4 (AUTHOR) ptyench@gmail.com |
| Source: | Journal of Translational Medicine. 1/13/2025, Vol. 23 Issue 1, p1-19. 19p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
